A practical guide to HIPAA-related healthcare marketing decisions: PHI, authorization, tracking technologies, vendor relationships, and safeguards.

Reviewed October 2026
Healthcare organizations can market their services, but they must determine when protected health information is involved and govern the communication, technology, and vendor relationship accordingly. HIPAA does not prohibit every digital marketing activity. It does create specific duties for HIPAA-regulated entities when they use or disclose protected health information, or PHI. A useful marketing program starts by separating general audience-building activity from patient information, then reviewing each workflow on its actual facts.
This guide explains general concepts for healthcare marketing and operations teams. It is not legal advice or a compliance determination. A practice’s privacy, security, compliance, and legal leaders should evaluate its services, audience, data flows, contracts, and applicable federal and state requirements.
The HIPAA Privacy and Security Rules apply to covered entities and business associates, not automatically to every organization that provides health-related information. A healthcare provider may be a covered entity when it meets HIPAA’s definition and conducts qualifying electronic transactions. Whether a particular campaign, webpage, list, form, or vendor relationship implicates HIPAA depends on whether it involves PHI and on the role of the parties involved.
PHI is individually identifiable health information held or transmitted by a covered entity or business associate. In a marketing setting, obvious examples can include patient records, appointment details, payment information, and health-related form submissions. Do not treat every website visitor, public content reader, or marketing-data field as PHI by default. At the same time, do not assume that a familiar marketing tool is outside HIPAA simply because it was installed for analytics or advertising.
Build a written data map before launching or changing a campaign. Identify what information is collected, where it comes from, which systems receive it, who can access it, how long it is retained, and the business purpose for each use. Then involve qualified stakeholders where the data or workflow may involve PHI.
HIPAA uses a specific definition of marketing. HHS describes it as a communication about a product or service that encourages recipients to purchase or use that product or service. With limited exceptions, a covered entity needs the individual’s written authorization before using or disclosing PHI for marketing.
Some communications are excluded from HIPAA’s definition of marketing. HHS identifies communications about certain health-related products or services provided by the covered entity, treatment communications, and certain case-management or care-coordination communications as examples. The fact that a message appears beneficial, routine, or patient-friendly does not settle the question. The organization should identify the communication’s purpose, the role of any third party, whether PHI is used, and whether a defined exception applies.
If a covered entity receives direct or indirect remuneration from a third party to disclose PHI so that the other party can market its own product or service, HHS treats that arrangement as marketing and the authorization must disclose the remuneration. A generic privacy notice, website cookie banner, or marketing preference should not be treated as a substitute for any HIPAA authorization the applicable facts require.
When the HIPAA minimum-necessary standard applies, the Privacy Rule requires reasonable efforts to use, disclose, or request only the amount of PHI needed for the intended purpose. In practical marketing operations, that means defining the purpose before selecting a list, field, event, segment, or report and limiting access to the people who need it.
A campaign should not use a full patient record, condition history, appointment detail, or care information merely because it is available in a system. Define the exact data element needed, the approved user or vendor, the permitted use, the retention approach, and the review owner. Keep treatment, payment, health care operations, marketing, and patient-preference decisions distinct in the campaign record.
Website tracking needs a page-by-page review. HHS explains that tracking technologies on authenticated webpages, including portals and telehealth platforms, generally have access to PHI. Many unauthenticated webpages do not involve PHI, but some unauthenticated workflows can. The presence of an analytics tag does not answer the question. Review what the page does, what information the tag or integration transmits, who receives it, and whether that information relates to an individual’s health, health care, or payment for care.
For example, public location and visiting-hours pages may not involve PHI. A public scheduling, intake, or symptom-related workflow may require a different analysis. HHS notes that an IP address plus a visit to an unauthenticated page about a condition or provider is not sufficient on its own to establish individually identifiable health information when the visit is not related to the individual’s health, health care, or payment for care. The actual facts remain important.
Audit page URLs and titles, form fields, query parameters, site-search terms, event names and values, tag-manager variables, advertising pixels, conversion APIs, chat, scheduling, maps, embedded tools, and custom code. For a detailed workflow, read the healthcare website tracking audit. For the Google Analytics-specific policy and page-scope question, read Is Google Analytics HIPAA Compliant?.
A vendor is not a business associate simply because it provides a technology service. The relationship must be evaluated based on what the vendor actually creates, receives, maintains, or transmits and on whose behalf. HHS explains that a vendor is a business associate when it creates, receives, maintains, or transmits PHI on behalf of a regulated entity for a covered function or a service that involves PHI.
When that relationship exists, the covered entity must ensure that the disclosure is permitted and enter into an appropriate business associate agreement. A signed agreement is not a complete program by itself. Document the vendor’s service, data flow, access model, permitted purpose, subcontractor role, security commitments, incident responsibilities, and the practice owner who reviews material changes.
Google states that it does not offer business associate agreements for Google Analytics and makes no representation that Analytics satisfies HIPAA requirements. HIPAA-regulated organizations using it should not expose Google to PHI. That product-specific limitation does not answer the status of every other analytics, advertising, scheduling, communication, or software vendor. Review each one separately.
The HIPAA Security Rule is flexible, scalable, and technology-neutral. It requires reasonable and appropriate administrative, physical, and technical safeguards for electronic PHI, based on the organization’s size, capabilities, systems, and risk. For marketing operations, that means assigning ownership, controlling access, training the workforce, documenting configuration decisions, maintaining incident procedures, and periodically reevaluating the system as tools and campaigns change.
Do not state that an email platform, text tool, CRM, chatbot, form tool, cloud environment, or AI product is “HIPAA compliant” based only on a sales claim or a business associate agreement. The organization should evaluate the intended workflow, contracts, configuration, access, data retention, integrations, and user behavior. The right safeguard is a fact-specific decision, not a generic checklist item.
Before sending a campaign or activating a new tool, document the audience, the exact communication, the data elements used, the purpose, the recipient systems, the business owner, and the relevant review decision. If PHI may be involved, add the privacy, security, compliance, legal, and vendor reviewers needed for the organization’s risk level.
After launch, validate that the real configuration matches the approved design. Review new tags, new integrations, modified forms, audience-list changes, platform features, agency access, and AI tools before they go live. If a potential impermissible disclosure is identified, preserve relevant information and follow the organization’s incident-response process. A technical finding alone does not determine whether a reportable breach occurred.
HIPAA is only one part of a responsible healthcare marketing program. Claims substantiation, testimonials, endorsements, advertising-platform policies, state rules, consumer-protection requirements, and internal approval controls may apply even where HIPAA does not. Use the companion healthcare marketing compliance governance framework for those broader campaign controls.
The practice’s privacy, security, compliance, and legal leaders should make the final decisions about HIPAA obligations, vendor agreements, authorizations, and incident response.